Legal
Learn more about our Legal work.
AdvaMed® Comment Letter to OIG’s Annual Solicitation for Safe Harbors and Special Fraud Alerts
AdvaMed urges OIG to modernize Anti-Kickback Statute safe harbors and issue a new fraud alert to support value-based care and expand access to medical technologies.
AdvaMed® Recommendations to CMS Regarding Sunshine Reporting Audits
AdvaMed®, the world’s leading medtech trade association, communicated to Centers for Medicaid & Medicare Services (CMS) recommendations regarding administration of the Open Payments program.
EcoFactor, Inc. v. Google LLC (US Court of Appeals) November 27, 2024
This case involves a patent infringement dispute between EcoFactor and Google, but the Court’s decision will reach every aspect of district court patent litigation in cases involving parties in every…
AdvaMed® Asks U.S. Court of Appeals to Support a Fair and Balanced Approach to Patent Damages
AdvaMed®, the Medtech Association, asked the United States Court of Appeals to support a fair and balanced approach to patent damages.
Edwards Lifesciences v. Meril Life Sciences (US Court of Appeals) November 18, 2024
The issue at hand is patent infringement and an overly broad interpretation of the Hatch-Waxman Act’s safe harbor. AdvaMed® pointed out that this would harm innovation. The decision has profound…
The End of Chevron Deference: What it Means for Medtech
The AdvaMed® Code of Ethics on Interactions with Health Care Professionals in China – the “AdvaMed® China Code” or “Code” – serves as a foundational charter for medical technology companies’…
Circuit Court Sides with Patient Safety and Medtech Innovators in Concluding that DMCA Exemptions are Subject to Judicial Review
In a decisive victory for medtech innovation, the D.C. Circuit Court of Appeals earlier this month held that the Digital Millennium Copyright Act (DMCA) regulations are judicially reviewable. Under this…
AdvaMed® Applauds D.C. Circuit Decision Restoring Judicial Oversight to Rulemaking that Impacts Patient Care
Today, The Advanced Medical Technology Association® (AdvaMed®) commended the U.S. Court of Appeals for the District of Columbia Circuit’s decision in the case Medical Imaging & Technology Alliance and Advanced…
What Chevron’s Demise Could Mean for Medtech
The Supreme Court will soon address the fate of agency deference—an issue presented in Relentless v. Department of Commerce and Loper Bright Enterprises v. Raimondo—in a ruling expected to have…